Wendy Diller
Senior Writer/Analyst/Director at MedTech Strategist
NYC business/ strategic writer interested in intersection of scientific innovation, biz & health. @MedTechStrat @innovationinmedtech
Articles
-
Oct 15, 2024 |
insights.citeline.com | Melanie Senior |Wendy Diller |John H Davis |Paul Bonanos
Deals Of The Week: Shire/Janssen, Pfizer/SFJ Pharma, AstraZeneca/IMS Health16 Jan 2012 • By Melanie Senior, Wendy Diller, John Davis, and Paul BonanosBesides the latest acquisition in the hepatitis C space, the week of the JP Morgan Healthcare Conference saw a spate of deals, including Shire doubling down on its bet on GI drug Resolor and Pfizer inking a pair of deals.
-
Jan 19, 2021 |
gothamgazette.com | Wendy Diller
-
Oct 30, 2018 |
innovationinmedtech.com | David Cassak |Wendy Diller
-
Sep 27, 2018 |
medtechstrategist.com | Mary Stuart |David Cassak |Wendy Diller |Colin Miller
-
Apr 19, 2018 |
innovationinmedtech.com | Stephen Levin |Wendy Diller
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 905
- Tweets
- 1K
- DMs Open
- No
RT @PeterHotez: So divide 0.52 by 1.52 and it’s closer to 30% than 70% (significant difference) + those added funds are used to support mis…
Amazing four days at @MiddleburyColle Labor Day weekend. Thx World class professor @ClintCave. Wonderful classmates and kudos to outstanding staff and vibrant participants from all over USA. Great start to fall 2023 https://t.co/VyVMt3FXbx
The #MetOpera JAMMED! Friday night dress up. Great #DonGiovanni https://t.co/jJrlehXRRW